Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Nutex Health (NUTX) Depreciation & Amortization (IS) (2021 - 2025)

Nutex Health's Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $5.2 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (IS) fell 1.78% year-over-year to $5.2 million; the TTM value through Dec 2025 reached $20.5 million, up 8.21%, while the annual FY2025 figure was $20.5 million, 8.21% up from the prior year.
  • Depreciation & Amortization (IS) for Q4 2025 was $5.2 million at Nutex Health, up from $5.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $5.3 million in Q4 2024 and bottomed at $1.9 million in Q3 2021.
  • The 5-year median for Depreciation & Amortization (IS) is $4.4 million (2022), against an average of $4.1 million.
  • The largest annual shift saw Depreciation & Amortization (IS) soared 131.34% in 2022 before it fell 1.78% in 2025.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $1.9 million in 2021, then skyrocketed by 74.8% to $3.3 million in 2022, then skyrocketed by 43.13% to $4.7 million in 2023, then grew by 12.77% to $5.3 million in 2024, then dropped by 1.78% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Depreciation & Amortization (IS) are $5.2 million (Q4 2025), $5.0 million (Q3 2025), and $5.2 million (Q2 2025).